BOULDER, Colo. (AP) — Federal regulators say a former manager at Boulder-based Array BioPharma Inc. will pay nearly $150,000 to settle allegations of insider trading.

The Daily Camera reports ( James L. Lieberman didn't admit any wrongdoing in the settlement.

Court records filed Monday show he would pay $147,628 in disgorgements of profits from the trading in question, interest and fines.

Lieberman was Array's manager of environmental health and safety from 2001 to 2010.

The Securities and Exchange Commission alleges he bought 49,763 shares of Array's stock in 2010 after learning a drug-development agreement with Novartis Inc. was imminent. That information wasn't public at the time.

The SEC alleges Lieberman sold the shares after the Novartis deal was publicly announced, earning $71,361.

Lieberman's phone number is unlisted, and he couldn't be reached for comment.


Information from: Daily Camera,